home / openregs / dockets

dockets: FDA-2020-P-1769

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: U.S. government sources, plus a few identifier registries; each is listed on the methodology page

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2020-P-1769 FDA Requests that the FDA amend the study design for the Phase III trial of mRNA-1273 (NCT04470427) to ensure that any and all adverse events and reactions will be documented for the entire duration of the trial; participants are tested for T-cell reactivity to SARS-CoV-2 pre-vaccination and post-vaccination. Nonrulemaking 2021-04-28T16:11:00Z 0b0000648480b7db   CLOSED     ["Citizen Petition", "CBER", "amend the study design for the Phase III trial", "of mRNA-1273 (NCT04470427)", "to ensure that", "any and all adverse events and reactions will be", "documented for the entire duration of the trial", "such documenting of adverse events and", "reactions shall last at least twelve", "months for adults", "thirty-six months for children", "and sixty months for infants and toddlers", "it uses an adequate sample size", "appropriately powered, in order to", "detect an increase in rare adverse", "events or any untoward medical occurrence", "whether or not considered vaccine", "related, and", "determine that the rate of adverse", "events from the vaccine", "will not exceed the rate of adverse events", "known to occur from SARS-CoV-2", "in the group under review", "participants are tested for T-cell reactivity", "to SARS-CoV-2 pre-vaccination", "and post-vaccination", "CLOSED"] CBER       {"displayProperties": [{"name": "abstract", "label": "General Information", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Description, Docket Subject, Related To, Summary."}, {"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}], "keywords": ["Citizen Petition", "CBER", "amend the study design for the Phase III trial", "of mRNA-1273 (NCT04470427)", "to ensure that", "any and all adverse events and reactions will be", "documented for the entire duration of the trial", "such documenting of adverse events and", "reactions shall last at least twelve", "months for adults", "thirty-six months for children", "and sixty months for infants and toddlers", "it uses an adequate sample size", "appropriately powered, in order to", "detect an increase in rare adverse", "events or any untoward medical occurrence", "whether or not considered vaccine", "related, and", "determine that the rate of adverse", "events from the vaccine", "will not exceed the rate of adverse events", "known to occur from SARS-CoV-2", "in the group under review", "participants are tested for T-cell reactivity", "to SARS-CoV-2 pre-vaccination", "and post-vaccination", "CLOSED"], "modifyDate": "2021-04-28T16:11:00Z", "dkAbstract": "CLOSED", "agencyId": "FDA", "program": "CBER", "shortTitle": null, "subType2": null, "title": "Requests that the FDA amend the study design for the Phase III trial of mRNA-1273 (NCT04470427) to ensure that any and all adverse events and reactions will be documented for the entire duration of the trial; participants are tested for T-cell reactivity to SARS-CoV-2 pre-vaccination and post-vaccination.", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "CLOSED", "effectiveDate": null, "objectId": "0b0000648480b7db"} single_get

Links from other tables

  • 9 rows from docket_id in documents
Powered by Datasette · Queries took 0.263ms · Data license: Public Domain (U.S. Government data) · Data source: U.S. government sources, plus a few identifier registries; each is listed on the methodology page · Privacy